Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Prepaid Assets (2018 - 2025)

X4 Pharmaceuticals (XFOR) has disclosed Prepaid Assets for 8 consecutive years, with $4.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Prepaid Assets rose 10.01% year-over-year to $4.9 million, compared with a TTM value of $4.9 million through Sep 2025, up 10.01%, and an annual FY2024 reading of $5.6 million, down 23.43% over the prior year.
  • Prepaid Assets was $4.9 million for Q3 2025 at X4 Pharmaceuticals, down from $5.0 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $7.3 million in Q4 2023 and bottomed at $3.6 million in Q1 2022.
  • Average Prepaid Assets over 5 years is $5.0 million, with a median of $5.0 million recorded in 2025.
  • The sharpest move saw Prepaid Assets skyrocketed 45.14% in 2021, then dropped 23.43% in 2024.
  • Year by year, Prepaid Assets stood at $5.3 million in 2021, then grew by 8.66% to $5.8 million in 2022, then increased by 25.68% to $7.3 million in 2023, then dropped by 23.43% to $5.6 million in 2024, then fell by 11.86% to $4.9 million in 2025.
  • Business Quant data shows Prepaid Assets for XFOR at $4.9 million in Q3 2025, $5.0 million in Q2 2025, and $4.5 million in Q1 2025.